Nowak-sliwinska, PatrycjaDyson, PaulGriffioen, ArjanWeiss, AndreaVan Den Bergh, HubertDing, Xianting2017-05-022017-05-022017-05-022017https://infoscience.epfl.ch/handle/20.500.14299/136999Angiogenesis inhibitory drug combination obtained according to a specific algorithm, preferably a FSC, in which an initial combination of drugs is iteratively adjusted. The drug combination according to the invention may advantageously comprise a RAPTA-C compound. In a more specific case the combination comprises RAPTA-C and eriotinib.patentUS2017014372EP3116485WO2015136061WO201513606152875103